HealthWatchlist verdict: A recent controlled trial provides a preliminary signal for frankincense during a stressful medical procedure. A separate workplace study tested a mixture without a control group. These findings support cautious interest in short-term relaxation, but do not establish treatment of a persistent anxiety disorder.
The claim now has some direct human evidence
Frankincense has a long association with calming rituals. That history can explain why people enjoy the scent, but it does not measure a treatment effect. The newer human studies are more directly relevant.
A randomised trial enrolled 120 men undergoing prostate biopsy. Participants received placebo, lavender or frankincense aroma during the procedure. There were 39 men in the frankincense group, and everyone received standard local anaesthesia.
The frankincense group’s anxiety scores fell after the procedure, while the control group showed little change. This is an encouraging procedural finding. It is not a study of everyday home use or long-term recovery from an anxiety disorder.
Read the reported comparisons carefully
The abstract’s large effect sizes describe changes within the groups. They should not be relabelled as the size of frankincense’s advantage over placebo. A before-and-after effect and a between-group treatment effect answer different questions.
Similarly, the pain comparison highlighted in the abstract concerns actual pain versus anticipated pain. That is not the same as demonstrating less actual pain than placebo. All participants also received local anaesthesia.
The trial was described as double-blind, although distinctive smells can make masking difficult. Its abstract does not establish whether participants successfully remained unaware of their allocation. Independent replication and fuller between-group reporting would improve confidence.
No adverse events were reported in this short trial. That does not establish safety for every user, device or repeated exposure. Its supervised nebuliser protocol is not a home-use instruction.
The nurses’ study cannot isolate frankincense
A pilot study followed 59 nurses using personal aroma inhalers for two weeks. The inhalers contained lavender, frankincense and bergamot. Perceived stress scores improved modestly.
This was a non-randomised before-and-after study without a control group. It can inform whether a larger trial is practical, but cannot establish that the mixture caused the change or identify frankincense’s contribution.
Workload, expectations, taking a pause and ordinary variation could influence stress ratings. A future comparison should help separate those effects, rather than assuming every improvement came from the oils.
The well-known brain mechanism was studied in mice
Research on incensole acetate investigated behaviour and TRPV3 channels in mice. Incensole acetate is a constituent associated with incense resin. An isolated compound in an animal experiment is not equivalent to a person smelling a retail essential oil.
This work provides a possible mechanism worth investigating. It does not show that a diffuser delivers the same exposure or that frankincense treats depression. A plausible pathway is not a substitute for a clinical outcome.
Resin, extract and distilled oil differ
An analysis of 21 commercial frankincense varieties found substantial differences in aroma composition. Species and origin matter. The study characterised resin aromas, not the effectiveness of different retail oils.
NCCIH distinguishes Boswellia extracts and frankincense uses, while noting limitations in the clinical evidence. Oral extract findings for other conditions should not be transferred to an inhaled relaxation claim.
Likewise, burning resin introduces a different exposure from using an unheated aroma product. Neither the biopsy trial nor the nurses’ pilot establishes that incense smoke is necessary or beneficial.
What the wider aromatherapy literature adds
A systematic review and network meta-analysis considered essential oils for anxiety. Its broad positive findings are useful context, but different oils, settings, controls and measures limit what can be inferred about one product.
We should not count a result for lavender as another frankincense trial. Nor should a pooled short-term anxiety score become a claim of remission from generalised anxiety disorder.
| Evidence | Scope |
|---|---|
| Controlled biopsy trial | Preliminary short-term procedural-anxiety signal. |
| Nurses’ mixed-oil pilot | Feasibility and before-and-after observations. |
| Incensole acetate in mice | Mechanistic research, not a human oil treatment. |
| Enjoying the scent | A personal preference, without proving disease treatment. |
A sensible place for a pleasant smell
If you enjoy frankincense, it can be an optional part of a comfortable relaxation routine. Stop exposure if it causes headache, coughing or irritation, and consider other people sharing the space.
Skin contact with essential oils can cause dermatitis. The inhalation findings do not justify concentrated skin application or swallowing oil. Avoid copying a clinical device protocol into a home nebuliser.
Persistent anxiety affecting daily life deserves assessment and evidence-based support. Talking therapies and, when appropriate, medicines address a different clinical need from enjoying a fragrance. A calming ritual should support rather than delay care.
Evidence score and conclusion
John’s Evidence Score: 3/10 for short-term relaxation or procedural-anxiety reduction with inhaled frankincense. Direct human research is emerging, but settings, reporting and replication limit confidence.
This is not a treatment score for generalised anxiety disorder. The fairest conclusion is a preliminary short-term signal, with much more work needed before broader clinical claims are justified.
How this review was researched
Research checked on 13 September 2026. We searched PubMed for the named oils or preparations and the condition, followed relevant review references, checked relevant trial-register results where available, and checked the official guidance linked below. This is an editorial review, not an exhaustive systematic review. We distinguish human treatment outcomes from laboratory findings, and identify where a study tested a mixture or a different preparation.
Related reading
- Frankincense oil profile
- Relaxation evidence overview
- Anxiety and essential oils
- Lavender relaxation evidence
References
- Aromatherapy effects on pain and anxiety during transrectal ultrasound-guided prostate biopsy: A randomized controlled trial.
- Aromatherapy to Reduce Stress in Nurses: A Pilot Study.
- Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain.
- Comparison and identification of aroma components in 21 kinds of frankincense with variety and region based on the odor intensity characteristic spectrum constructed by HS-SPME-GC-MS combined with E-nose.
- NCCIH: Boswellia
- Benefit of inhalation aromatherapy as a complementary treatment for stress and anxiety in a clinical setting – A systematic review.
- DermNet: Allergic contact dermatitis to essential oils
- NHS: Generalised anxiety disorder